| pubmed-article:17361995 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17361995 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:17361995 | lifeskim:mentions | umls-concept:C0226896 | lld:lifeskim |
| pubmed-article:17361995 | lifeskim:mentions | umls-concept:C0205531 | lld:lifeskim |
| pubmed-article:17361995 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:17361995 | lifeskim:mentions | umls-concept:C1527415 | lld:lifeskim |
| pubmed-article:17361995 | lifeskim:mentions | umls-concept:C0205177 | lld:lifeskim |
| pubmed-article:17361995 | lifeskim:mentions | umls-concept:C1413516 | lld:lifeskim |
| pubmed-article:17361995 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
| pubmed-article:17361995 | lifeskim:mentions | umls-concept:C1880355 | lld:lifeskim |
| pubmed-article:17361995 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:17361995 | pubmed:dateCreated | 2007-4-12 | lld:pubmed |
| pubmed-article:17361995 | pubmed:abstractText | A series of beta-carboxamido-phosphon(in)ic acids (2) was identified as a new structural motif for obtaining potent inhibitors of human mast cell chymase. For example, 1-naphthyl derivative 5f had an IC50 value of 29 nM and (E)-styryl derivative 6g had an IC50 value of 3.5 nM. An X-ray structure for 5f.chymase revealed key interactions within the enzyme active site. Compound 5f was selective for inhibiting chymase versus eight serine proteases. Compound 6h was orally bioavailable in rats (F=39%), and orally efficacious in a hamster model of inflammation. | lld:pubmed |
| pubmed-article:17361995 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17361995 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17361995 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17361995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17361995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17361995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17361995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17361995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17361995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17361995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17361995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17361995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17361995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17361995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17361995 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17361995 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:17361995 | pubmed:issn | 0022-2623 | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:SavvidesSavva... | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:MaryanoffBruc... | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:Di... | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:HallJeffreyJ | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:GrecoMichael... | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:HawkinsMichae... | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:PowellEugene... | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:AlmondHarold... | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:CorcoranThoma... | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:WangYuanpingY | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:CantwellAngel... | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:DamianoBruce... | lld:pubmed |
| pubmed-article:17361995 | pubmed:author | pubmed-author:MinorLisa KLK | lld:pubmed |
| pubmed-article:17361995 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17361995 | pubmed:day | 19 | lld:pubmed |
| pubmed-article:17361995 | pubmed:volume | 50 | lld:pubmed |
| pubmed-article:17361995 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17361995 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17361995 | pubmed:pagination | 1727-30 | lld:pubmed |
| pubmed-article:17361995 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:meshHeading | pubmed-meshheading:17361995... | lld:pubmed |
| pubmed-article:17361995 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17361995 | pubmed:articleTitle | Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase. | lld:pubmed |
| pubmed-article:17361995 | pubmed:affiliation | Research and Early Development, Johnson & Johnson Pharmaceutical Research and Development, Spring House, Pennsylvania 19477-0776, USA. mgreco@prdus.jnj.com | lld:pubmed |
| pubmed-article:17361995 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:17361995 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17361995 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17361995 | lld:pubmed |
